Stumpy, call me an optimist, however, subsequent to reflection,...

Stumpy, call me an optimist, however, subsequent to reflection, I think its a healthy sign/event that has enabled SG to increase the value of their holding and so prima facie recoup some value lost initially and over the interim years. Logically, I would like to think that this will expedite FML progress and redeem value from their patient strategy i.e. accumulating inferred and reserve Au oz. Unlike others, and being empathetic to who they are, fate and what transpired, I commend their strategy. Perhaps not laced with the normal Aussie shareholder expectations in this sector, however, as the Buffet would say....strong research and patience are prudent with the latter being a virtue.

Having said that, let 2022 unfold and see how close to the mark I am.